vs

Side-by-side financial comparison of ZoomInfo Technologies Inc. (GTM) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.

HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $319.1M, roughly 4.2× ZoomInfo Technologies Inc.). ZoomInfo Technologies Inc. runs the higher net margin — 10.9% vs 7.3%, a 3.6% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs 3.2%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $127.1M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 1.4%).

ZoomInfo Technologies Inc. is a registered data broker in the United States. The company collects and sells personal data, both public and private, through various means of data and web scraping. Information about business entities like companies and departments are also collected and offered. These personal information are available for sale, where other businesses can use the collected data for targeted marketing.

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

GTM vs HAE — Head-to-Head

Bigger by revenue
HAE
HAE
4.2× larger
HAE
$1.3B
$319.1M
GTM
Growing faster (revenue YoY)
HAE
HAE
+1.6% gap
HAE
4.8%
3.2%
GTM
Higher net margin
GTM
GTM
3.6% more per $
GTM
10.9%
7.3%
HAE
More free cash flow
HAE
HAE
$82.8M more FCF
HAE
$209.9M
$127.1M
GTM
Faster 2-yr revenue CAGR
HAE
HAE
Annualised
HAE
99.2%
1.4%
GTM

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
GTM
GTM
HAE
HAE
Revenue
$319.1M
$1.3B
Net Profit
$34.7M
$97.3M
Gross Margin
84.0%
14.9%
Operating Margin
17.0%
83.4%
Net Margin
10.9%
7.3%
Revenue YoY
3.2%
4.8%
Net Profit YoY
137.7%
-42.0%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GTM
GTM
HAE
HAE
Q1 26
$1.3B
Q4 25
$319.1M
$339.0M
Q3 25
$318.0M
$327.3M
Q2 25
$306.7M
$321.4M
Q1 25
$305.7M
$330.6M
Q4 24
$309.1M
$348.5M
Q3 24
$303.6M
$345.5M
Q2 24
$291.5M
$336.2M
Net Profit
GTM
GTM
HAE
HAE
Q1 26
$97.3M
Q4 25
$34.7M
$44.7M
Q3 25
$38.7M
$38.7M
Q2 25
$24.0M
$34.0M
Q1 25
$26.8M
$58.0M
Q4 24
$14.6M
$37.5M
Q3 24
$23.8M
$33.8M
Q2 24
$-24.4M
$38.4M
Gross Margin
GTM
GTM
HAE
HAE
Q1 26
14.9%
Q4 25
84.0%
59.7%
Q3 25
83.7%
59.5%
Q2 25
83.9%
59.8%
Q1 25
84.5%
58.4%
Q4 24
82.8%
55.5%
Q3 24
84.4%
54.2%
Q2 24
84.3%
52.0%
Operating Margin
GTM
GTM
HAE
HAE
Q1 26
83.4%
Q4 25
17.0%
19.9%
Q3 25
21.2%
17.9%
Q2 25
17.5%
16.8%
Q1 25
16.5%
21.6%
Q4 24
10.0%
16.9%
Q3 24
14.3%
15.0%
Q2 24
-6.9%
11.8%
Net Margin
GTM
GTM
HAE
HAE
Q1 26
7.3%
Q4 25
10.9%
13.2%
Q3 25
12.2%
11.8%
Q2 25
7.8%
10.6%
Q1 25
8.8%
17.5%
Q4 24
4.7%
10.8%
Q3 24
7.8%
9.8%
Q2 24
-8.4%
11.4%
EPS (diluted)
GTM
GTM
HAE
HAE
Q1 26
Q4 25
$0.11
$0.95
Q3 25
$0.12
$0.81
Q2 25
$0.07
$0.70
Q1 25
$0.08
$1.17
Q4 24
$0.04
$0.74
Q3 24
$0.07
$0.66
Q2 24
$-0.07
$0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GTM
GTM
HAE
HAE
Cash + ST InvestmentsLiquidity on hand
$179.9M
$245.4M
Total DebtLower is stronger
$1.3B
$1.2B
Stockholders' EquityBook value
$1.5B
$796.3M
Total Assets
$6.4B
$2.4B
Debt / EquityLower = less leverage
0.88×
1.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GTM
GTM
HAE
HAE
Q1 26
$245.4M
Q4 25
$179.9M
$363.4M
Q3 25
$135.0M
$296.4M
Q2 25
$176.9M
$292.9M
Q1 25
$140.5M
$306.8M
Q4 24
$139.9M
$320.8M
Q3 24
$147.7M
$299.3M
Q2 24
$399.3M
$344.4M
Total Debt
GTM
GTM
HAE
HAE
Q1 26
$1.2B
Q4 25
$1.3B
$1.2B
Q3 25
$1.3B
$1.2B
Q2 25
$1.3B
$1.2B
Q1 25
$1.2B
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Stockholders' Equity
GTM
GTM
HAE
HAE
Q1 26
$796.3M
Q4 25
$1.5B
$911.5M
Q3 25
$1.5B
$849.2M
Q2 25
$1.6B
$882.3M
Q1 25
$1.6B
$820.8M
Q4 24
$1.7B
$906.9M
Q3 24
$1.7B
$878.9M
Q2 24
$1.9B
$905.4M
Total Assets
GTM
GTM
HAE
HAE
Q1 26
$2.4B
Q4 25
$6.4B
$2.5B
Q3 25
$6.4B
$2.4B
Q2 25
$6.5B
$2.5B
Q1 25
$6.4B
$2.5B
Q4 24
$6.5B
$2.5B
Q3 24
$6.4B
$2.5B
Q2 24
$6.7B
$2.5B
Debt / Equity
GTM
GTM
HAE
HAE
Q1 26
1.53×
Q4 25
0.88×
1.34×
Q3 25
0.87×
1.44×
Q2 25
0.85×
1.39×
Q1 25
0.75×
1.49×
Q4 24
0.72×
Q3 24
0.74×
Q2 24
0.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GTM
GTM
HAE
HAE
Operating Cash FlowLast quarter
$143.5M
$293.2M
Free Cash FlowOCF − Capex
$127.1M
$209.9M
FCF MarginFCF / Revenue
39.8%
15.7%
Capex IntensityCapex / Revenue
5.1%
2.5%
Cash ConversionOCF / Net Profit
4.14×
3.01×
TTM Free Cash FlowTrailing 4 quarters
$389.3M
$417.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GTM
GTM
HAE
HAE
Q1 26
$293.2M
Q4 25
$143.5M
$93.6M
Q3 25
$93.8M
$111.3M
Q2 25
$108.9M
$17.4M
Q1 25
$119.2M
$116.6M
Q4 24
$109.0M
$43.8M
Q3 24
$18.2M
$48.8M
Q2 24
$126.3M
$-27.4M
Free Cash Flow
GTM
GTM
HAE
HAE
Q1 26
$209.9M
Q4 25
$127.1M
$87.2M
Q3 25
$70.9M
$106.3M
Q2 25
$86.9M
$13.6M
Q1 25
$104.4M
$100.9M
Q4 24
$85.6M
$35.2M
Q3 24
$600.0K
$39.4M
Q2 24
$115.2M
$-33.1M
FCF Margin
GTM
GTM
HAE
HAE
Q1 26
15.7%
Q4 25
39.8%
25.7%
Q3 25
22.3%
32.5%
Q2 25
28.3%
4.2%
Q1 25
34.2%
30.5%
Q4 24
27.7%
10.1%
Q3 24
0.2%
11.4%
Q2 24
39.5%
-9.8%
Capex Intensity
GTM
GTM
HAE
HAE
Q1 26
2.5%
Q4 25
5.1%
1.9%
Q3 25
7.2%
1.5%
Q2 25
7.2%
1.2%
Q1 25
4.8%
4.7%
Q4 24
7.6%
2.5%
Q3 24
5.8%
2.7%
Q2 24
3.8%
1.7%
Cash Conversion
GTM
GTM
HAE
HAE
Q1 26
3.01×
Q4 25
4.14×
2.09×
Q3 25
2.42×
2.88×
Q2 25
4.54×
0.51×
Q1 25
4.45×
2.01×
Q4 24
7.47×
1.17×
Q3 24
0.76×
1.44×
Q2 24
-0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons